...
首页> 外文期刊>International Journal of Research in Medical Sciences >Effect of grey zone sample testing of transfusion transmissible infectious diseases on safety of blood-experience of a tertiary care referral teaching hospital blood bank from South India
【24h】

Effect of grey zone sample testing of transfusion transmissible infectious diseases on safety of blood-experience of a tertiary care referral teaching hospital blood bank from South India

机译:印度南部三级转诊教学医院血库的输血传播性传染病的灰色区域样本测试对血液体验安全性的影响

获取原文
           

摘要

Background: Grey zone samples with optical density (OD) lying between cut-off OD and 10% below the cut-off OD (cut-off OD × 0.9) were identified during routine transfusion transmissible infectious disease (TTIs) screening. Enzyme-linked immunosorbent assay (ELISA) used for this purpose can sometimes fail to detect blood donors who are recently infected or possessing the low viremia. Estimation of a grey zone in ELISA testing and repeat testing of grey zone samples can further help in reducing the risks of TTI in countries where nucleic acid amplification testing for TTIs is not feasible. Methods: On performing repeat ELISA testing on grey zone samples in duplicate, the samples showing both OD values below grey zone were marked nonreactive, and samples showing one or both OD value in the grey zone were marked indeterminate. The samples on repeat testing showing one or both OD above cut-off value were labelled reactive. Results: Of the 21,908 blood donors screened during the study period, a total of 144 blood donors were found to be in grey zone. On repeat testing of these grey zone samples, 35 (24.30%) were found to be reactive for TTIs. Conclusions: Estimation of grey zone samples with repeat testing can further enhance the safety of blood transfusion in resource poor developing nations where more sophisticated and sensitive methods such as nucleic acid amplification test (NAT) is not available in all the blood banks.
机译:背景:在常规输血传播性传染病(TTIs)筛查中,鉴定出灰色区域样品的光密度(OD)在截止OD和低于截止OD(截止OD×0.9)的10%之间。用于此目的的酶联免疫吸附测定(ELISA)有时可能无法检测到最近被感染或具有低病毒血症的供血者。在无法进行TTI核酸扩增测试的国家/地区,在ELISA测试中估计灰色区域和对灰色区域样品进行重复测试可进一步帮助降低TTI的风险。方法:一式两份地对灰色区域样品进行重复ELISA测试时,显示两个位于灰色区域以下的OD值的样品均标记为非反应性,而显示一个或两个位于灰色区域中的OD值的样品标记为不确定。重复测试中显示出一个或两个OD值超出临界值的样品被标记为反应性的。结果:在研究期间筛查的21908名献血者中,共有144名献血者位于灰色区域。在对这些灰色区域样品进行重复测试时,发现有35种(24.30%)对TTI具有反应活性。结论:在资源贫乏的发展中国家中,通过重复测试来估计灰色区域的样本可以进一步提高输血的安全性,因为在这些贫民中并非所有血库中都提供了更复杂,更敏感的方法,例如核酸扩增测试(NAT)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号